|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0024305,
umls-concept:C0031268,
umls-concept:C0032743,
umls-concept:C0046056,
umls-concept:C0085101,
umls-concept:C0392762,
umls-concept:C0549193,
umls-concept:C0871261,
umls-concept:C1552861,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C1882440,
umls-concept:C2911692
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2010-2-16
|
|
pubmed:abstractText |
Radioimmunotherapy (RIT) is a new treatment option for patients with non-Hodgkin lymphoma (NHL). Response to RIT currently remains difficult to predict using conventional prognostic factors and could be refined using functional imaging. The goal of this work is to evaluate the value of (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in predicting response to Yttrium 90-labeled monoclonal antibodies for patients with NHL.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1619-7089
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
37
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
494-504
|
|
pubmed:meshHeading |
pubmed-meshheading:19820933-Adult,
pubmed-meshheading:19820933-Aged,
pubmed-meshheading:19820933-Aged, 80 and over,
pubmed-meshheading:19820933-Female,
pubmed-meshheading:19820933-Fluorodeoxyglucose F18,
pubmed-meshheading:19820933-Follow-Up Studies,
pubmed-meshheading:19820933-Fuzzy Logic,
pubmed-meshheading:19820933-Glycolysis,
pubmed-meshheading:19820933-Humans,
pubmed-meshheading:19820933-Lymphoma, Non-Hodgkin,
pubmed-meshheading:19820933-Male,
pubmed-meshheading:19820933-Middle Aged,
pubmed-meshheading:19820933-Positron-Emission Tomography,
pubmed-meshheading:19820933-Radioimmunotherapy,
pubmed-meshheading:19820933-Retrospective Studies,
pubmed-meshheading:19820933-Treatment Outcome,
pubmed-meshheading:19820933-Tumor Burden
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Pre-therapy 18F-FDG PET quantitative parameters help in predicting the response to radioimmunotherapy in non-Hodgkin lymphoma.
|
|
pubmed:affiliation |
Service de Médecine Nucléaire et Imagerie Fonctionnelle, CHU Lille, 59000, Lille, France. cazathom@hotmail.com
|
|
pubmed:publicationType |
Journal Article
|
